0074-5015 : Skyrizi 60 mg/ml Intravenous Injection


NDC: 0074-5015
Labeler: Abbvie Inc.
Product Type: Human Prescription Drug
Drug Name:  Skyrizi
Dosage Form: Intravenous Injection
Application #: BLA761262
Rev. Date: 


NDC Package Codes:

  • 0074-5015-01: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (0074‑5015‑01) > 10 ML IN 1 VIAL, SINGLE‑DOSE
  • 0074-5015-02: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (0074‑5015‑02) > 10 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Risankizumab

Dosage Strength:

  • 600 mg/10mL

Pharmaceutical Classes:

  • Interleukin-23 Antagonist [EPC]
  • Interleukin-23 Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0074-1050 Skyrizi 150 mg/ml Subcutaneous Injection by Abbvie Inc.
  • 0074-1065 SkyriziSkyrizi Kit by Abbvie Inc.
  • 0074-1070 SkyriziSkyrizi Kit by Abbvie Inc.
  • 0074-2042 SkyriziSkyrizi Kit by Abbvie Inc.
  • 0074-2100 Skyrizi 150 mg/ml Subcutaneous Injection by Abbvie Inc.
  • 0074-7034 SkyriziSkyrizi Kit by Abbvie Inc.
  • 0074-7036 SkyriziSkyrizi Kit by Abbvie Inc.
  • 0074-7040 SkyriziSkyrizi Kit by Abbvie Inc.
  • 0074-7042 SkyriziSkyrizi Kit by Abbvie Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0074-5015 QR Code

< Prev: 0074-4637Next: 0074-5182 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.